health
RevMed’s pancreatic cancer pill priced above $475,000 a year

Revolution Medicines Inc. won U.S. approval for a breakthrough pill that lengthens the lives of patients with advanced pancreatic cancer, a major advance against one of the hardest-to-treat tumor types.
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories

Dad says he went permanently blind
New York Post

I'm a woman in my 20s and I'm not have the sex I want. I know what's holding me back.
Slate

Millions of cancer cases are linked to 5 common infections: study
New York Post

45-year-old man died after ER sent him home without antibiotics, lawsuit says
OregonLive.com
19 Harmless Symptoms That Are Major Medical Red Flags
BuzzFeed